SAGENT PHARMACEUTICALS INC - COM (SGNT)

CUSIP: 786692103

Q3 2013 13F Holders as of 30 Sep 2013

Type / Class
Equity / COM
Total 13F shares
95,227
Share change
+66,813
Total reported value
$1,944,000
Price per share
$20.42
Number of holders
4
Value change
+$1,363,725
Number of buys
3

Quarterly Holders Quick Answers

What is CUSIP 786692103?
CUSIP 786692103 identifies SGNT - SAGENT PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SAGENT PHARMACEUTICALS INC - COM (SGNT) as of Q3 2013

As of 30 Sep 2013, SAGENT PHARMACEUTICALS INC - COM (SGNT) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 95,227 shares. The largest 4 holders included PDT Partners, LLC, Citadel Advisors LLC, BANK OF MONTREAL /CAN/, and WELLS FARGO & COMPANY/MN. This page lists 4 institutional shareholders reporting positions in this security for the Q3 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.